Changes in the structure of healthcare delivery will affect patients, physicians, insurers and pharmaceutical companies
PENNINGTON, N.J., July 14, 2011 /PRNewswire/ -- The 2010 health-care reform law calls for the creation of accountable-care organizations – or ACOs – which will change who pays for healthcare and how much they will pay.
They are already changing the structure of the healthcare market. By one estimate, the accountable-care market is expected to be an $80 billion business.
Only companies that are putting the resources in place today will be able to capture this new market and prosper tomorrow.
And only one company – HYGEIA Consulting Group – has compiled the information the pharmaceutical industry needs to serve these new customers, prepare their organizations and become leaders in transforming healthcare.
"Accountable Care in Progress: Review of Policy, Approaches to Implementation and Implications for the Pharmaceutical Industry" includes exclusive interviews with 25 experts and leaders of healthcare delivery organizations and participation in key meetings with stakeholders around the country.
What are ACOs?
ACOs are intended to incent physicians, hospitals and insurers to work together to deliver better patient care at lower costs.
One insurer figures ACOs can save 40 percent over the current fee-for-service system and has invested millions in preparing for ACOs.
With the 2010 law and Medicare's rulings outlining ACO requirements, the discussion has moved from policy experts to insurers, practitioners, hospitals, and many other providers.
The HYGEIA report:
- Describes the structure of ACOs
- Surveys what providers, insurers, and pharmaceutical companies are doing
- Highlights emerging leaders
- Evaluates how ACOs will change the healthcare marketplace
Purchase by July 31, 2011, and receive HYGEIA's "Bonus Report: Compendium of Healthcare Organizations Poised to Implement ACOs" – its exclusive research into 12 healthcare organizations – at no additional cost!
With its unique combination of experience and expertise in government, industry and academia, HYGEIA serves the diverse needs of multiple stakeholders in the healthcare system. www.hygeiacg.com
Dr. Julie Stafford, principal and founder, is trained as a research psychologist and has worked for more than 20 years in academic medical institutions, the pharmaceutical industry and healthcare consulting. Her specialty is evaluating and managing complex systems. She is the leader in understanding ACOs' impact on the pharmaceutical industry.
SOURCE HYGEIA Consulting Group